Compare MasTec Inc (MTZ) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasTec Inc vs Novartis AG — how do they compare? MasTec Inc trades at $350.55 (market cap $26.60B), while Novartis AG trades at $153.88 (market cap $290.25B). The key difference: Novartis AG is far larger — about 10.9× MasTec Inc's market cap, and Novartis AG pays a 3.17% dividend while MasTec Inc pays none. Which is the better fit depends on your goals.
| MTZ | NVS | |
|---|---|---|
Market Cap | $26.60B | $290.25B |
Sector | Technology | Health |
52-Week High | $437.51 | $168.62 |
52-Week Low | $172.51 | $113.50 |
Enterprise Value | $29.34B | $330.27B |
Dividend Yield | — | 3.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MasTec Inc
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
